Sunday, 15 June 2025
Afternoon session: Registration fee inclusive with Summit registration.
General Objective: To advance the region towards the aspiration of “Zero Dengue Deaths” through enhanced collaboration, innovation, and strategic implementation.
Key Objectives:
(1) Strengthen Regional Surveillance & Early Warning: Foster the development and adoption of robust, integrated surveillance systems for early detection and prediction of dengue outbreaks across Asia, considering the Philippines’ specific challenges.
(2) Optimize Clinical Management & Patient Outcomes: Share best practices and establish standardized protocols for timely diagnosis, effective clinical care, and efficient management of dengue cases, particularly for severe dengue and vulnerable populations in resource-limited settings.
(3) Accelerate Innovative Vector Control Strategies: Discuss and promote the implementation of novel and sustainable vector control methods, including community-based approaches and technological advancements, tailored to diverse regional contexts like the Philippines.
(4) Advance Dengue Vaccine Development & Implementation: Review progress in vaccine research and explore strategies for equitable access and effective deployment of available and future dengue vaccines.
(5) Enhance Multi-Sectoral Collaboration & Advocacy: Forge stronger partnerships among governments, healthcare professionals, researchers, industry, and communities to mobilize resources, streamline policies, and amplify public awareness for comprehensive dengue prevention and control.
TIME | PROGRAMME | SPEAKER/S |
1200 – 1300 | Registration | |
1300 – 1310 | Opening Remarks | Cesar M. Ong
Nicodemus Jr Nemencio A |
Pearls in Clinical Management of Dengue | ||
1310 – 1315 | Introductory session, overview of dengue
Introduce workshop objectives |
Fatima I. Gimenez |
Workshops on Clinical Management | Chair: Janice Caoili | |
1315 – 1345 | Classification of Dengue Diagnostics in Clinical Management |
Suzette Urbano- Cruz |
1345 – 1400 | Life Stage (Infancy to Adolescent, Adult) | LakKumar Fernando |
1400 – 1430 | 1. Dengue without warning signs – OPD management in the public and private setting |
Arthur Dessi Roman |
1430 – 1500 | 2. Dengue with warning signs – inpatient management in a secondary/tertiary setting |
Ma. Charmian Hufano |
1500 – 1530 | 3. Severe dengue (no co-morbidities) | Thea Pamela Cajulao |
1530 – 1545 | Expert Panel Q & A |
Lucy Lum Chai See |
1545 – 1600 | Coffee break | |
1600 – 1630
1630 – 1700 |
Severe Dengue and Its Complications (Sri Lanka Experiences)
Dengue in Special Populations |
LakKumar Fernando
Jemelyn Garcia |
1700 – 1730 | PPS Dengue Integrated Program Pediatric Clinical Management |
Florentina Ty |
1730 – 1745 | Expert Panel Q & A |
Lucy Lum Chai See |
1745 – 1755 | Summary and Conclusion | Kristine Dela Cruz |
DAY 1 (June 16, 2025)
TIME | PROGRAMME | SPEAKER/S |
0730 – 0800 | Registration | |
Opening Ceremonies | ||
0800 – 0810 | Introduction to Asia Dengue Summit Dengue in the Philippines: A Continuing Public Health Challenge |
Maria Rosario Capeding |
0810 – 0820 | Welcome Address | DOH Representative (TBC) |
0820 – 0850 | Keynote Address:
Dengue and Global Health |
Moderator: Tikki Pangestu
Manuel Dayrit |
0850 – 0900 | Welcome Performance | |
0900 – 0910 | Coffee Break | |
The evolving epidemiology of Dengue: country experiences – gains, challenges, and ways forward | ||
0910 – 0940 | Preview of Lancet Commission Findings | Oliver J. Brady |
0940 – 1020 | Dengue in the Midst of Climate Change (Singapore / Philippines) | Ng Lee Ching
Venus Ivy Cloma Rosales |
1020 – 1040 | Dengue Epidemiology: Modeling the Future | Angkana T. Huang |
1030 – 1050 | Dengue Pathogenesis | Ooi Eng Eong |
1050 – 1100 | Welcome Performance II | |
1100 – 1200 | Industry Sponsored Symposium:
New Diagnostic Differential Approaches to Achieving Zero Dengue Deaths’ Ambition |
BioMerieux
Ramon V. Najarro |
1200 – 1245 | Lunch, poster viewing, visit to exhibitors’ booths Group Photo |
|
Dengue pathogenesis and management – navigating best practice options in resource-limited settings | ||
1245 – 1305 | Dengue viruses are not monolithic | Nathan Grubaugh |
1305 – 1400 | Testing of Dengue: Use Cases Across the Control and Care Continuum
|
Panel Discussion: Kristine Dela Cruz (Moderator)Panelists: Raul Destura Rukie de AlwisRontgene Solante |
1400 – 1445 | ADVA Educational Symposium Supported by DNDi :
Dengue and the missing cure: Why are therapeutics still absent? |
Panel Discussion:
Neelika Malavige |
1445 – 1500 | Coffee break Poster viewing |
|
1500 – 1520 | Dengue Human Infection Model – Filling the Immunology Knowledge Gaps | Adam Waickman |
1520 – 1620 | Best practices in Clinical Management of Dengue: | Panel Discussion: Jo-Anne De Castro (Moderator)Nattachai Srisawat Janice Caoili Ramon Najaro Hasitha Tissera Somia Iqtadar LakKumar Fernando |
1620 – 1700 | Dengue Immunity – Lessons from the Field | Michelle Ylade Laura Rivino |
1700 – 1720 | Dengue Immunity – Lessons from Clinical Trials | Shirin Kalimuddin |
1720 – 1730 | Summary and Close of Day 1 | Francesca Mae Pantig |
DAY 2 (June 17, 2025)
TIME | PROGRAMME | SPEAKER/S |
0730 – 0810 | Registration | |
0810 – 0830 | Key Learnings from the Clinical Management Workshop | Lucy Lum Chai See Lakkumar Fernando |
Dengue vaccine updates and innovations | ||
0830 – 0930 | Modelling the efficacy and impact of the Dengue Vaccine
Mass vaccination during dengue outbreak Dengue Vaccine Policy Making |
Ilaria Dorigatti
Albert Ko Kim Mulholland |
0930 – 1030 | Real-world experience with dengue vaccine:
Thailand |
Sunate Chuenkitmongkol William Stephenson Tjeng Fernando Bozza |
1030 – 1045 | Coffee break Poster viewing |
|
1045 – 1145 | Industry-sponsored Symposium
Dengue Defense: |
Takeda
Nikki Kitikiti (Moderator) Shirin Kalimuddin |
1145 – 1225 | Lunch, poster viewing, visit to exhibitors’ booths | |
1225 – 1315 | Research oral presentations – by invitation only.
|
|
Policy, Advocacy, Research and Innovation Co-Chairs: Hasitha Tissera & Maria Rosario Capeding |
||
1315 – 1335 | Predictive modelling for prediction and prevention of dengue outbreaks | Lim Jue Tao |
1335 – 1435 | Chair: Hasitha Tissera | |
Vector control and implementation
Challenges to Vector Control in the Philippines Human Movement Drives Dengue Transmission |
Katie Anders
Frances E. Edillo Martin Hibberd |
|
1435 – 1455 | Coffee break, poster viewing | |
1455 – 1615 | Dengue Slayers Challenge (ADVA-JA) |
Grand Final |
1615 – 1715 | Advocacy, communication and collaboration
“Changes worldwide in dengue advocacy – what has been achieved and what still needs to be done” Effective Communication Strategies Call to Action |
Moderator: Lulu Bravo
Marianne Comparet Panel Discussion: |
1715 – 1730 | Prize Ceremony for Dengue Slayers Challenge (ADVA-JA) |
Photo-Taking |
1730 – 1750 | Summary and close of day 2 | Francesca Mae Pantig Maria Rosario Capeding |
POST-SUMMIT WORKSHOP (June 18, 2025)
Operational Workshop: Integrating Wolbachia into dengue prevention programs. Supported by World Mosquito Program
TIME | PROGRAMME | SPEAKER/S |
0800 – 0850 | Registration | |
0850 – 0900 | Welcome | Tracy Loh |
0900 – 0930 | Best Practices for the implementation of Wolbachia for dengue control | Peter Ryan |
0930 – 1000 | Case Study: Implementation of Wolbachia in Indonesia | Riris Andono Ahmad |
1000 – 1020 | Morning Tea | |
1015 – 1045 | Case Study: Implementation of Wolbachia in New Caledonia | Nadege Rossi |
1045 – 1115 | Case Study: Large-scale roll out of Wolbachia in Brazil | Luciano Moreira |
1115 – 1200 | Panel Discussion: Cross Country reflections on Wolbachia implementation | Chair: Cam Watson Panel: Peter Ryan Riris Andono Ahmad Nadege Rossi Luciano Moreira |
1200-1210 | Closing Remarks | Tracy Loh |
POST-SUMMIT Workshop Proper:
Title: Operational Workshop – Integrating Wolbachia replacement into dengue prevention programs
Synopsis:
This half-day workshop will introduce the Wolbachia replacement method, highlight its impact on dengue prevention, and feature perspectives from countries on implementing Wolbachia programs. Through presentations, practical case studies, and an open Q&A, participants will:
- Increase understanding of Wolbachia-based dengue prevention, including core principles, key operational steps, and real-world impacts.
- Gain practical insights on planning, implementing, and monitoring Wolbachia replacement programs
- Learn from the experiences of countries who are implementing Wolbachia replacement programs, drawing on their successes, challenges, and lessons learned.
- Engage in discussion among public health officials, policy makers, donors, and technical experts on how Wolbachia replacement can be integrated into existing vector control programs.
Who should attend:
As spaces are limited, access will be prioritized to people working in the following areas:
- Ministry of Health officials responsible for dengue control programs
- Vector control staff wanting to understand more about implementing Wolbachia initiatives
- Donors interested in funding or supporting Wolbachia initiatives
- Representatives from regional and international health agencies and non governmental organizations
Registration Fee: Peso 500 / USD10
This workshop is limited to 50 participants, and a nominal registration fee is required to secure your spot. The fee includes a tea/coffee break and light refreshments.
Spaces are limited and will be allocated on a first-come, first-served basis, so early registration is encouraged.
For more information, contact secretariat@adva.asia or francis@adva.asia